Isomorphic Labs
AI-first drug discovery platform that applies protein-structure prediction and generative models to design therapeutic candidates
Funding
$2.70B
2026
Details
Headquarters
London, United Kingdom
CEO
Sir Demis Hassabis
Website
Milestones
FOUNDING YEAR
2021
Listed In
News
The latest coverage and announcements from Isomorphic Labs.